Breaking News

AbbVie Joins ORIEN Research Exchange

Aims to advance cancer research through R&D collaboration initiative

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie has joined the Oncology Research Information Exchange Network (ORIEN) Avatar Research Program, which fosters collaboration among key stakeholders in cancer research with the goal of discovering and developing new therapies in clinical trials.    ORIEN Avatar is a collaboration among the 15 leading U.S. cancer hospitals that comprise ORIEN, pharmaceutical companies, and M2Gen, a health informatics company that manages the program. AbbVie is the fourth pharma company to participate in t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters